Navigation Links
Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
Date:10/18/2010

SAN DIEGO, Oct. 18 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.  This line is located in Althea's large scale & commercial manufacturing facility in San Diego. The expanded capacity complements existing prefilled syringe manufacturing for clinical supplies and allows Althea to provide its clients with drug product in prefilled syringes from early development through commercial supply.

(Logo:  http://photos.prnewswire.com/prnh/20020925/LAW010LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

The INOVA H3-5 syringe line operates within a Restricted Access Barrier System (RABS) and incorporates the ability to fill under vacuum, which facilitates handling of viscous products and products that require minimal head space.  The line accommodates nested syringes from a variety of suppliers and can produce batch sizes in excess of 100,000 units.  The system incorporates non-destructive, in-process weight checks to minimize product loss.  Rick Hancock, President of Contract Manufacturing Services at Althea Technologies, commented, "We've been filling syringes for clinical use for over eight years, and the addition of this new line allows us to continue to meet client requirements as they progress from late stage development through commercialization."

The prefilled syringe market is rapidly expanding as it provides numerous benefits relating to patient compliance and product differentiation.  "With our existing expertise in formulation development and protein analytics, we can now offer clients an integrated solution to quickly develop, register, and launch their products in prefilled syringes," added Dr. Shabbir Anik, CEO of Althea Technologies.

The line will be available for production of GMP batches in Q1, 2011.  Please visit the Althea Technologies website for more detailed information about the new, large scale syringe filling capabilities.

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization.  Althea's technology platform for protein formulations employs crystalomics that can be applied to a variety of peptide and proteins for high concentration or sustained release formulations.  For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
2. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
3. Visonic Technologies Announces the Immediate Availability of its Elpas Door Kit, an All-in-One Starter Kit Packaged With Everything Required to Install a Single-Door Wandering Patient and Resident Protection Solution
4. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
5. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
6. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
7. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
8. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
9. HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
10. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
11. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):